New research reveals 80% of England does not have an effective pathway for the early detection of liver disease despite huge rises in deaths.
Leading liver charity says prevention measures are still ‘woefully inadequate’ New research published today in the British Journal of General Practice reveals that 80% of regional health bodies in England lack an effective pathway to diagnose and manage liver disease,...
Politicians, policymakers, clinicians and patients unify to call for action: Hepatitis B – Breaking the Silence
Politicians, clinicians and policy makers joined us on Wednesday 4th December at the House of Commons to add their support for our new report, Hepatitis B – Break the Silence. We are urging politicians to commit to action, so that the UK can meet the World Health...
Patient advocate volunteers raise awareness of liver disease among members of Parliament
The British Liver Trust’s policy team works hard to raise awareness of liver disease and liver cancer with the Government and other lawmakers, highlighting the urgent need for early diagnosis and campaigning for improved treatment and care for patients. Patient...
More evidence of the importance of opt-out hepatitis B and C testing
A new report launched today provides yet more evidence for The British Liver Trust’s call for routine, opt-out hepatitis B and hepatitis C testing. The report shares the latest findings from the Emergency department bloodborne virus opt-out testing programme. In total...